Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06023329Phase 4Suspended
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by University of Minnesota. Started May 2024; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06023329.